Star Health Share Price: Profit mein **200X** se zyada ka dhamaka! Naye Targets bhi aaye

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Star Health Share Price: Profit mein **200X** se zyada ka dhamaka! Naye Targets bhi aaye
Overview

Bhaiyo aur Behno, Star Health Insurance ke investors ke liye badi khabar! Company ne Q4 mein **₹111 crore** ka profit kamaya hai, jo pichhle saal ke sirf **₹51 lakh** ke muqable **200X** se bhi zyada hai. Lekin, ek twist hai - company ne apne future growth targets ko thoda kam kar diya hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Q4 Profits Mein Dhamaka!

Star Health ne Q4 mein kamaal kar diya hai! Net profit ₹111 crore tak pahunch gaya, pichhle saal ke ₹51 lakh ke aage toh yeh 200X se bhi zyada growth hai. Gross Written Premium (GWP) bhi 16% badh kar ₹5,968 crore ho gaya. Company ke CFO, Nilesh Kambli, bata rahe hain ki iska reason hai underwriting mein improvement, loss-making group insurance se bahar nikalna, aur prices ko thoda adjust karna, especially bank indemnity segment mein. Is wajah se overall loss ratio 68.7% par aa gaya hai, aur retail loss ratio 68.2% ho gaya hai.

Ind-AS Adoption Ka Asar

Jab se Ind-AS accounting standards adopt kiye hain ( April 1, 2026 se), FY26 ka profit ₹911 crore raha, jo FY25 ke ₹787 crore se zyada hai. Yeh naya accounting system financial performance ko aur clear dikha raha hai.

Targets Kam Kiye, Profit Pe Dhyaan

FY26 mein GWP ₹20,369 crore tak pahunch gaya, lekin company ne FY28 ka GWP target thoda kam kar diya hai. Pehle yeh ₹30,000 crore tha, ab ₹27,500 crore kar diya hai. Iska matlab ye hai ki company ab sirf volume nahi, balki profitability par zyada focus karegi, especially group insurance mein jo itna faydemand nahi tha. Ye industry trend ke hisaab se sahi move lag raha hai.

Valuation Aur Market Ka Trend

Abhi valuation ki baat karein toh Star Health ka P/E ratio 67.6x hai, jo ICICI Lombard ( 31.88x ) jaise competitors se kaafi high hai. Market cap lagbhag ₹30,317 crore hai. Indian health insurance market toh bomb phod raha hai, USD 16 billion se USD 39 billion tak jaayega 2032 tak, issi wajah se Sabko growth dikh rahi hai. Analysts bhi 'Buy' rating de rahe hain aur average target price ₹528.14 diya hai, matlab thoda aur upside possible hai. Stock pichhle saal 29.58% bhi badha hai.

Challenges Aur Aage Kya?

Lekin bhai, sab kuch itna bhi smooth nahi hai. Itna high P/E maintain karna ek bada challenge hai. Profit par focus karne se market share growth thoda slow ho sakti hai, kyunki competitors tez se expand kar rahe hain. Regulatory changes aur IRDAI ke rules bhi dhyan mein rakhne honge. Company ko cybersecurity lapses ke liye ₹3.39 crore ka penalty bhi laga tha, jo operational risks dikhata hai. Lekin, Ind-AS adoption se financial performance aur clear hogi aur reported ratios improve honge. Overall, management ab growth aur profitability ko balance karne ki koshish kar raha hai, aur Indian health insurance market ki growth toh pakki hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.